Quick recap The meeting focused on the recent media hysteria surrounding Kratom, particularly the misrepresentation of synthetic products as natural Kratom in news reports. Christopher expressed frustration with the media's lack of distinction between natural Kratom and synthetic substances, which has led to public confusion and fear. The group discussed the need for regulation and education to differentiate between safe, natural Kratom and dangerous synthetic products. They shared strategies for engaging with media and policymakers, emphasizing the importance of personal stories and humanizing the Kratom community. The conversation also touched on the challenges posed by bad actors in the industry, the role of politics in the current situation, and the potential impact of upcoming elections on Kratom policy. Participants shared personal experiences and advocacy efforts, highlighting the need for a national conversation about the benefits and risks of Kratom. Summary Kratom Media Coverage Concerns Christopher expressed frustration over recent media coverage of Kratom, noting that news stations across the country are incorrectly discussing synthetic Kratom products without waiting for toxicology results. He attributed the media focus partly to upcoming midterm elections and suggested that officials like Sarah Carter are contributing to the confusion by discussing Kratom without distinguishing between natural and synthetic forms. Christopher mentioned reaching out to multiple news stations daily to correct the narrative and noted that even his family members have contacted him seeking clarification about the media reports. Kratom Overdose Case Discussion The group discussed a recent overdose case involving synthetic Kratom pills, with Christopher expressing skepticism about media coverage and speculation surrounding the incident. Michael suggested the substance might be MGM-16, a potent synthetic opioid, while Drew noted that toxic screening results would be needed to confirm the substance's identity. The discussion highlighted concerns about regulatory approaches to Kratom, with Christopher arguing that proper regulation should have been implemented years ago rather than banning products, which would likely lead to underground sales of potentially more dangerous substances.

Quick recap The meeting focused on the recent Kratom-related deaths of two University of Mississippi students, Aiden Hamilton and Robert Strang, which has sparked widespread media coverage and regulatory concerns. Christopher shared a video of Sarah Carter, the Drug Czar, distinguishing between natural Kratom leaf and synthetic derivatives like 7-OH, which were recently emergency scheduled by the DEA. The group discussed how synthetic Kratom products containing MGM15 and other contaminants have damaged the reputation of the natural leaf, with Christopher noting that legitimate vendors like himself have suffered while bad actors continue to operate. They examined the possibility of contamination rather than direct toxicity, comparing it to other drug cases where substances were found at scenes but may not have been the actual cause of death. The conversation also covered broader issues around drug regulation, the difference between natural Kratom and synthetic products, and concerns about media coverage that may not distinguish between the two. Summary Kratom Media Coverage Concerns Christopher discussed concerns about media coverage of Kratom, particularly highlighting Sean Hannity's misleading presentation of the substance and Sarah Carter's distinction between natural Kratom leaf and synthetic products. Michael shared a disturbing dream about being blamed as a fugitive in a Kratom-related incident, reflecting the group's shared anxiety about the current media coverage. The participants expressed frustration that media outlets are misrepresenting what Kratom actually is, with many people believing it's a synthetic drug rather than a natural leaf from Southeast Asia. Kratom Regulatory and Safety Concerns Christopher, Michael, and Venus discussed the recent media attention surrounding Kratom, particularly in Mississippi and Maryland, where concerns about contamination and regulatory issues have emerged. Christopher shared a news article about illegal Kratom samples found in Maryland containing fentanyl and other substances, highlighting the need for stricter regulations and enforcement. The group expressed frustration with the rapid spread of misinformation and the challenges in addressing the situation effectively.

MGM-15 and MGM-16 are fully synthetic compounds, and they are far more potent and pharmacologically distinct than 7-hydroxymitragynine (7-OH). While 7-OH occurs naturally in the kratom leaf in trace amounts and acts as a relatively short-lived partial agonist at the mu-opioid receptor, MGM-15 and MGM-16 are fully synthetic analogs engineered for stronger and longer receptor activation. Laboratory binding assays, such as the [³⁵S]GTPγS binding studies shown in the figure, demonstrate that both MGM compounds display significantly higher efficacy and affinity than 7-OH or even traditional opioid reference compounds. This means they engage the opioid system more intensely and for longer durations, placing them in an entirely different pharmacological category from natural kratom alkaloids. In short, 7-OH is a minor metabolite; MGM-15 and MGM-16 are potent designer opioids. A new review in Drug Testing and Analysis highlights the rise of semi-synthetic compounds derived from kratom alkaloids (often called “MGM-15” series) and related potent analogs, including MGM-15 and MGM-16. These differ fundamentally from traditional, plain-leaf kratom. U.S. regulators now move to control 7-hydroxymitragynine (7-OH) due to opioid-like risk profiles, while not targeting the natural kratom leaf. To further understand these compounds, it’s essential to recognize the historical context of kratom use. Traditionally, kratom has been utilized for its various therapeutic properties by indigenous communities in Southeast Asia. This long-standing tradition is based on the plant's natural benefits, including relief, increased energy, and enhanced mood. As the kratom market evolved, it began to attract a wider audience, leading to an influx of products that often prioritize potency over safety. This shift has raised concerns about the quality and integrity of the kratom being consumed.

“Gas station heroin” is not science. It is a fear-based slogan built by combining a retail location with the name of an unrelated drug. To expose how ridiculous that logic is: - Alcohol = “gas station Xanax” - Energy drinks = “gas station Adderall” - Cigarettes = “gas station cocaine” - Sleep aids = “gas station sedatives” - Cough medicine = “gas station ketamine” - Lottery tickets = “gas station gambling addiction” These are intentionally exaggerated comparisons, not claims that the products are pharmacologically identical. That is the point: dramatic nicknames distort rather than educate. I am tired of catchy headlines calling kratom “gas station heroin.” That is not science. It is lazy, sensationalized branding. If we applied the same ridiculous logic to everything sold in a convenience store, we could call: Alcohol “gas station Xanax.” Energy drinks “gas station Adderall.” Cigarettes “gas station cocaine.” Cough medicine “gas station ketamine.” Sleep aids “gas station sedatives.” Those comparisons would be misleading because retail location does not determine a product’s chemistry, effects, or risks. The same standard must apply to kratom. Natural kratom leaf is not heroin. Mitragynine is not heroin. A traditional botanical tea does not become heroin because somebody sells it at a gas station. Are poorly formulated, mislabeled, adulterated, and chemically manipulated products being sold under the kratom name? Absolutely. That is a legitimate problem, and regulators should address it. But calling every kratom product “gas station heroin” erases the enormous difference between natural leaf, concentrated extracts, isolated 7-hydroxymitragynine, and synthetic or semisynthetic compounds. Inspect the product. Test the chemistry. Read the laboratory report. Adjust based on what is actually inside the package. Facts and science beat catchy headlines every time. https://x.com/compose/articles/edit/2100662521233629184